About the Atopic Eczema Session
Atopic eczema, also known as atopic dermatitis, is a chronic skin condition that is characterized by dryness, inflammation, and itching. It is most common in children, but can affect adults as well. Atopic eczema is caused by a combination of genetic and environmental factors, and is often associated with allergies, asthma, and hay fever. Atopic eczema can be mild, moderate, or severe. It typically appears on the face, behind the knees, and inside the elbows and wrists. Signs and symptoms may include red, itchy, and inflamed skin, scaly patches, dry patches, cracking and crusting, and small bumps with fluid in them. Treatment for atopic eczema includes emollients (moisturizers) and topical corticosteroids, which can be applied directly to the affected area. Emollients help to soothe the skin, reduce dryness, and reduce inflammation. They may also reduce the need for topical corticosteroids. In severe cases, immunosuppressants and biologic medications may be recommended. It is also important to avoid triggers, which may be anything from environmental allergens and stress to certain fabrics and detergents. A diet that avoids known food allergies may also help. Atopic eczema is not curable, but it can be managed with proper treatment. By avoiding triggers, using emollients, and following a treatment plan, it is possible to relieve symptoms and prevent the condition from becoming more serious.
Featured Speakers — Atopic Eczema 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Atopic Eczema Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IDC 2027
Why Attend the Atopic Eczema Conference 2027
Present Your Research
Oral and poster slots for original Atopic Eczema work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Atopic Eczema research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same program, same certificate.
Join IDC 2027 for the Atopic Eczema track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Atopic Eczema Conference 2027 — FAQs
What is the Atopic Eczema track at IDC 2027?
The Atopic Eczema track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Atopic Eczema. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Atopic Eczema sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Atopic Eczema are all welcome — whether presenting or attending.
Can I present my research in the Atopic Eczema track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Atopic Eczema sessions?
Yes. IDC 2027 is a hybrid conference — attend the Atopic Eczema track in person in Rome or join live online, with on-demand access afterward.
Join the IDC 2027 delegation
Rome · June 21–23, 2027 · Hybrid · in-person & virtual
Attend without presenting.

